July 30, 2021

CAAR – US House Committee on Energy and Commerce, Subcommittee on Health Hearing Testimony – July 30, 2021

Filed under: Legislation Information Updates — Tags: — admin @ 5:36 pm

The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases,” a hearing held July 29, 2021 (hearing testimony available in .pdf format, video of the full hearing available at the site, running time 5 hours 11 minutes). Note: Panel 1 starts at the 13:30 mark and ends at the 2:19:15 mark. Panel 2 starts at the 6:47:00 mark.

CAAR – US Centers for Disease Control Article – July 30, 2021

Filed under: Reports and Articles — Tags: , — admin @ 5:34 pm

Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021,” by James T. Lee, Sandy P. Althomsons, Hsiu Wu, Daniel S. Budnitz, Elizabeth J. Kalayil, Megan C. Lindley, Cassandra Pingali, Carolyn B. Bridges, Andrew I. Geller, Amy Parker Fiebelkorn, Samuel B. Graitcer, James A. Singleton, and Suchita A. Patel (Morbidity and Mortality Weekly Report, Vol. 70, No. 30, July 29, 2021, .pdf and HTML format, p. 1036-1039).

CAAR – US National Institutes of Health Funding Opportunities – July 30, 2021

Filed under: Employment/Funding Opportunities — Tags: — admin @ 5:33 pm

BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed),” (RFA-MH-21-235, National Institute of Aging, in conjunction with other agencies, application deadline November 9, 2021). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed),” (RFA-MH-21-236); and, “BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed),” (RFA-MH-21-237).

Powered by WordPress